Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19Gabriella d’Ettorre, Claudio Maria Mastroianni, Giancarlo Ceccarelli et al.|Frontiers in Medicine|2020Cited by 218
Probiotic supplementation promotes a reduction in T‐cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART‐treated HIV‐1‐positive patientsGabriella d’Ettorre, Vincenzo Vullo, Giacomo Rossi et al.|Immunity Inflammation and Disease|2017Cited by 105
A pilot study on the effects of probiotic supplementation on neuropsychological performance and micro<scp>RNA</scp>‐29a‐c levels in antiretroviral‐treated<scp>HIV</scp>‐1‐infected patientsGiancarlo Ceccarelli, Gabriella d’Ettorre, Mariangela Fratino et al.|Brain and Behavior|2017Cited by 60
Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severityFederica Frasca, Carolina Scagnolari, Mirko Scordio et al.|European Journal of Immunology|2022Cited by 58
Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected IndividualsGiancarlo Ceccarelli, Gabriella d’Ettorre, Vincenzo Vullo et al.|Nutrients|2017Cited by 51